Munchenstein, Switzerland

Rene Hersperger


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Basel, CH (2012)
  • Munchenstein, CH (1999 - 2013)

Company Filing History:


Years Active: 1999-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Rene Hersperger

Introduction

Rene Hersperger is a notable inventor based in Munchenstein, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 4 patents to her name, her work continues to impact the industry.

Latest Patents

Among her latest patents are innovative compounds that have potential therapeutic applications. One of her patents focuses on Aryl carboxylic acid cyclohexyl amide derivatives, which are described as a compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof. The variants R and X are defined in the specification, showcasing the complexity and specificity of her work. Another significant patent involves Chemokine receptor antagonists, which also describes a compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, with variants R, R9, Z, X, Q, and Y defined in the specification.

Career Highlights

Rene Hersperger is currently employed at Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of her notable coworkers include Philipp Janser and Wolfgang Miltz, who work alongside her in advancing pharmaceutical innovations.

Conclusion

Rene Hersperger's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a significant inventor. Her work continues to pave the way for new therapeutic options in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…